Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Brain-computer interface training with feedback for arm use after stroke

Compares two feedback types in brain-computer interface training for adults after left-hemisphere stroke.

Plain-language title generated from the registry record
Registry title: Evaluation of an Adaptive Neurotechnology Based on Motor Imagery in Patients Who Suffered a Left Hemisphere Stroke

Key facts

Where
Buenos Aires, ArgentinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT07875257, who can take part

Where in Argentina

  • FleniBuenos Aires, ArgentinaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia
Trial code
NCT07875257
Record updated
15 October 2026
Original description
This randomized clinical trial will evaluate the feasibility and performance of a co-adaptive motor imagery brain-computer interface (BCI) for upper-limb rehabilitation in adults with subacute left-hemisphere stroke. The study will investigate whether continuous neurofeedback improves BCI control and learning compared with binary feedback based on correct or incorrect task performance. Participants will be randomly assigned to a neurofeedback group or a group receiving binary feedback. The intervention consists of BCI calibration followed by 10 real-time BCI training sessions. EEG and surface EMG signals will be recorded throughout the BCI sessions. BCI performance will be assessed using decoding accuracy and the algorithmic support provided by the Supportive Backward Adaptation (SBA) method, together with motor and neurophysiological measures.Read full original descriptionShow less

Evaluation of an Adaptive Neurotechnology Based on Motor Imagery in Patients Who Suffered a Left Hemisphere Stroke

This randomized clinical trial will evaluate the feasibility and performance of a co-adaptive motor imagery brain-computer interface (BCI) for upper-limb rehabilitation in adults with subacute left-hemisphere stroke. The study will investigate whether continuous neurofeedback improves BCI control and learning compared with binary feedback based on correct or incorrect task performance. Participants will be randomly assigned to a neurofeedback group or a group receiving binary feedback. The intervention consists of BCI calibration followed by 10 real-time BCI training sessions. EEG and surface EMG signals will be recorded throughout the BCI sessions. BCI performance will be assessed using decoding accuracy and the algorithmic support provided by the Supportive Backward Adaptation (SBA) method, together with motor and neurophysiological measures.

Inclusion: Age between 18 and 65 years; Medical diagnosis of a first left hemisphere stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI) or clinical evaluation; Stroke occurred within the last 90 days; Brunnstrom recovery stage III-V for the upper limb and Brunnstrom recovery stage II-V for the hand; Ashworth score ≤2 in elbow flexors and finger flexors; Score in the attention/executive function dimension of the Montreal Cognitive Assessment (MoCA): ≥ 3; Mild to moderate aphasia: on the NIHSS scale, aphasia subscore ≤2 points; No right homonymous hemianopia as determined by visual field confrontation.

Exclusion: Patients with tracheostomies, intracranial metallic implants, metallic pacemakers, or craniotomies; Individuals with a neurological or psychiatric condition that would preclude participation in the study; Individuals with a history of trauma or rheumatological conditions affecting the mobility of the right upper limb; Individuals with skin damage at the electrode contact point, infection, or allergy to the electrodes; Individuals with any medical contraindication to participating in the protocol; Individuals not currently participating in an upper limb research protocol.

ClinicalTrials.gov NCT07875257